Grundläggande statistik
| CIK | 1852432 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to ARYA Sciences Acquisition Corp V - Class A
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| February 14, 2024 |
SC 13G/A 1 aryea221424.htm 683 CAPITAL MANAGEMENT, LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* ARYA Sciences Acquisition Corp V (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G31658100 (CUSIP Number) December 31, 2023 (Date of Event which R |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* ARYA Sciences Acquisition Corp V (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G31658100 (CUSIP Number) July 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate b |
|
| July 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-40595 ARYA SCIENCES ACQUISITION CORP V (Exact name of registrant as spe |
|
| July 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ARYA Sciences Acquisition Corp V (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G31658100 (CUSIP Number) June 30, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box |
|
| July 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 3, 2023 ARYA SCIENCES ACQUISITION CORP V (Exact name of registrant as specified in its charter) Cayman Islands 001-40595 98-1590338 (State or other jurisdiction of incorporation) |
|
| July 3, 2023 |
Exhibit 99.1 ARYA Sciences Acquisition Corp V will redeem its Class A Ordinary Shares and will not consummate an initial business combination New York, July 3, 2023 – ARYA Sciences Acquisition Corp V (the “Company”) (Nasdaq: ARYE), a special purpose acquisition company, today announced that as of the close of business on July 14, 2023, the Company’s publicly held Class A ordinary shares, par value |
|
| June 13, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ D |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* ARYA SCIENCES ACQUISITION CORP V. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G31658100 (CUSIP Number) May 15, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ARYA SCIENCES ACQUISITION CORP V (Exact name of regist |
|
| April 12, 2023 |
Subsidiaries of ARYA Sciences Acquisition Corp V Exhibit 21 Subsidiaries of ARYA Sciences Acquisition Corp V None. |
|
| April 12, 2023 |
Description of Registrant’s Securities* Exhibit 4.2 ARYA SCIENCES ACQUISITION CORP V DESCRIPTION OF SECURITIES The following summary of the material terms of the securities of ARYA Sciences Acquisition Corp V is not intended to be a complete summary of the rights and preferences of such securities and is subject to and qualified by reference to our amended and restated memorandum and articles of association and applicable Cayman Islands |
|
| April 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40595 ARYA SCIENCES ACQ |
|
| April 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2023 ARYA SCIENCES ACQUISITION CORP V (Exact name of registrant as specified in its charter) Cayman Islands 001-40595 98-1590338 (State or other jurisdiction of incorporatio |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER: 001-40595 CUSIP NUMBER: G31658100 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form N-CSR ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on |
|
| February 14, 2023 |
ARYE / ARYA Sciences Acquisition Corp V Class A / CITADEL ADVISORS LLC - SC 13G/A Passive Investment SC 13G/A 1 tm233236-4sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 2)* ARYA Sciences Acquisition Corp V (Name of Issuer) Class A Ordinary Share, par value $0.0001 per sh |
|
| February 14, 2023 |
ARYE / ARYA Sciences Acquisition Corp V Class A / Sculptor Capital LP - SC 13G/A Passive Investment SC 13G/A 1 d445284dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* ARYA SCIENCES ACQUISITION CORP V (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G31658100 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing o |
|
| February 14, 2023 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. 1)* ARYA Sciences Acquisition Corp V (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G31658100 (CUSIP Number) Dec |
|
| February 14, 2023 |
ARYE / ARYA Sciences Acquisition Corp V Class A / ARISTEIA CAPITAL LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| November 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ARYA SCIENCES ACQUISITION CORP V (Name of Issuer) Class A Ordinary Share, $0.0001 par value (Title of Class of Securities) G31658100 (CUSIP Number) November 23, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to des |
|
| November 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ARYA SCIENCES ACQUISITION CORP V (Exact name of re |
|
| August 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ARYA SCIENCES ACQUISITION CORP V (Exact name of registr |
|
| May 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ARYA SCIENCES ACQUISITION CORP V (Exact name of regist |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ARYA SCIENCES ACQUISITION CORP V (Exact name of registr |
|
| March 31, 2022 |
Subsidiaries of ARYA Sciences Acquisition Corp V Exhibit 21 Subsidiaries of ARYA Sciences Acquisition Corp V None. |
|
| March 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ARYA SCIENCES ACQUISITION CORP |
|
| March 15, 2022 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 10, 2022 ARYA SCIENCES ACQUISITION CORP V (Exact name of registrant as specified in its charter) Cayman Islands (State or other jurisdiction of incorporation or organization) 001-40595 (Commi |
|
| March 4, 2022 |
ARYE / ARYA Sciences Acquisition Corp V Class A / Sculptor Capital LP - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ARYA SCIENCES ACQUISITION CORP V (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G31658100 (CUSIP Number) January 24, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 (Amendment No. 1)* ARYA Sciences Acquisition Corp V (Name of Issuer) Class A Ordinary Share, par value $0.0001 per share (the ?Shares?) (Title of Class of Sec |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* ARYA Sciences Acquisition Corp V (Name of Issuer) Class A ordinary shares, $0.0001 par value per share (Title of Class of Securities) G31658100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the Appropriate |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ARYA SCIENCES ACQUISITION CORP V (Name of Issuer) Class A Ordinary Share, $0.0001 par value (Title of Class of Securities) G31658100 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to desi |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ARYA SCIENCES ACQUISITION CORP V (Exact name of re |
|
| August 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ARYA SCIENCES ACQUISITION CORP V (Exact name of registr |
|
| August 27, 2021 |
Description of Registrant’s Securities(3) Exhibit 4.2 ARYA SCIENCES ACQUISITION CORP V DESCRIPTION OF SECURITIES The following summary of the material terms of the securities of ARYA Sciences Acquisition Corp V is not intended to be a complete summary of the rights and preferences of such securities and is subject to and qualified by reference to our amended and restated memorandum and articles of association and applicable Cayman Islands |
|
| July 26, 2021 |
SC 13G 1 tm2123249d2sc13g.htm ARYA SCIENCES ACQUISITION CORP V UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* ARYA Sciences Acquisition Corp V (Name of Issuer) Class A ordinary shares, pa |
|
| July 26, 2021 |
EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the Class A ordinary shares of ARYA Sciences Acquisition Corp V, a Cayman Islands exempted company, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amen |
|
| July 23, 2021 |
ARYE / ARYA Sciences Acquisition Corp V Class A / 683 Capital Management, LLC Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. )* ARYA Sciences Acquisition Corp V (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G31658100 (CUSIP Number) July |
|
| July 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ARYA SCIENCES ACQUISITION CORP V. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G31658100 (CUSIP Number) July 13, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| July 21, 2021 |
ARYA SCIENCES ACQUISITION CORP V Exhibit 99.1 ARYA SCIENCES ACQUISITION CORP V Report of Independent Registered Public Accounting Firm F-2 Balance Sheet F-3 Notes to Financial Statement F-4 Report of Independent Registered Public Accounting Firm To the Shareholders and the Board of Directors of ARYA Sciences Acquisition Corp V Opinion on the Financial Statement We have audited the accompanying balance sheet of ARYA Sciences Acqui |
|
| July 21, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 21, 2021 (July 15, 2021) ARYA SCIENCES ACQUISITION CORP V (Exact name of registrant as specified in its charter) Cayman Islands (State or other jurisdiction of incorporation or o |
|
| July 15, 2021 |
Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of July 15, 2021 by and between ARYA Sciences Acquisition Corp V, a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, Fi |
|
| July 15, 2021 |
Letter Agreement among the Company, the Sponsor and the Company’s officers and directors.(1) Exhibit 10.4 July 12, 2021 ARYA Sciences Acquisition Corp V 51 Astor Place, 10th Floor New York, New York 10003 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into by and among ARYA Sciences Acquisition Corp V, a Cayman Islands exempted company (th |
|
| July 15, 2021 |
Amended and Restated Memorandum and Articles of Association.(1) Exhibit 3.1 Companies Act (Revised) Company Limited by Shares amended and restated memorandum of association OF ARYA Sciences Acquisition Corp V Adopted by special resolution on 12 July 2021 Companies Act (Revised) Company Limited by Shares Amended and Restated Memorandum of Association of ARYA Sciences Acquisition Corp V Adopted by special resolution on 12 July 2021 1 The name of the Company is A |
|
| July 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 15, 2021 (July 12, 2021) ARYA SCIENCES ACQUISITION CORP V (Exact name of registrant as specified in its charter) Cayman Islands (State or other jurisdiction of incorporation or o |
|
| July 15, 2021 |
Exhibit 10.3 REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT THIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (this ?Agreement?), dated as of July 15, 2021, is made and entered into by and among ARYA Sciences Acquisition Corp V, a Cayman Islands exempted company (the ?Company?), ARYA Sciences Holdings V, a Cayman Island exempted limited company (the ?Sponsor?), and the undersigned parties listed u |
|
| July 15, 2021 |
Administrative Services Agreement between the Company and the Sponsor.(1) Exhibit 10.5 ARYA SCIENCES ACQUISITION CORP V 51 Astor Place, 10th Floor New York, New York 10003 July 15, 2021 ARYA Sciences Holdings V c/o Perceptive Advisors 51 Astor Place, 10th Floor New York, New York 10003 Ladies and Gentlemen: This letter will confirm our agreement that, commencing on the effective date (the ?Effective Date?) of the registration statement (the ?Registration Statement?) for |
|
| July 15, 2021 |
13,000,000 Class A Ordinary Shares ARYA Sciences Acquisition Corp V UNDERWRITING AGREEMENT EX-1.1 2 nt10022624x6ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 13,000,000 Class A Ordinary Shares ARYA Sciences Acquisition Corp V UNDERWRITING AGREEMENT July 12, 2021 JEFFERIES LLC GOLDMAN SACHS & CO. LLC As Representatives of the several Underwriters c/o JEFFERIES LLC 520 Madison Avenue New York, New York 10022 c/o GOLDMAN SACHS & CO. LLC 200 West Street New York, New York 10282 Ladies and Gentlemen: In |
|
| July 15, 2021 |
Private Placement Shares Purchase Agreement between the Company and the Sponsor.(1) Exhibit 10.1 PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT THIS PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), dated as of July 12, 2021, is entered into by and between ARYA Sciences Acquisition Corp V, a Cayman Islands exempted company (the ?Company?), and ARYA Sciences Holdings V, a Cayman Islands |
|
| July 14, 2021 |
$130,000,000 ARYA Sciences Acquisition Corp V 13,000,000 Class A Ordinary Shares TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(4) Registration No. 333-257335 PROSPECTUS $130,000,000 ARYA Sciences Acquisition Corp V 13,000,000 Class A Ordinary Shares ARYA Sciences Acquisition Corp V is a newly organized blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reor |
|
| July 12, 2021 |
8-A12B 1 brhc100267918a12b.htm 8-A12B SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ARYA SCIENCES ACQUISITION CORP V (Exact name of registrant as specified in its charter) Cayman Islands 98-1590338 (State or other jurisdiction of incorporation or organiza |
|
| June 24, 2021 |
EX-99.4 19 nt10022624x2ex99-4.htm EXHIBIT 99.4 Exhibit 99.4 CONSENT OF DEBRA YU ARYA Sciences Acquisition Corp V intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersig |
|
| June 24, 2021 |
Exhibit 3.1 EXEMPTED Company Registered and filed as No. 371938 On 22-Feb-2021 Acting Assistant Registrar Dated 22 February 2021 Companies Act (Revised) Company Limited by Shares MEMORANDUM OF ASSOCIATION OF ARYA SCIENCES ACQUISITION CORP V Auth Code: E69405119550 www.verify.gov.ky EXEMPTED Company Registered and filed as No. 371938 On 22-Feb-2021 Acting Assistant Registrar Companies Act (Revised) |
|
| June 24, 2021 |
Form of Indemnity Agreement.(2) Exhibit 10.4 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of [?], 2021, by and between ARYA Sciences Acquisition Corp V, a Cayman Islands exempted company (the ?Company?), and (?Indemnitee?). WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provided with adequ |
|
| June 24, 2021 |
Exhibit 99.3 CONSENT OF SANJIV K. PATEL ARYA Sciences Acquisition Corp V intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the ?Registration Statement?) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named in th |
|
| June 24, 2021 |
Exhibit 10.7 ARYA Sciences Acquisition Corp V c/o Perceptive Advisors 51 Astor Place, 10th Floor New York, NY 10003 March 18, 2021 ARYA Sciences Holdings V c/o Perceptive Advisors 51 Astor Place, 10th Floor New York, NY 10003 RE: Securities Subscription Agreement Gentlemen: This agreement (this ?Agreement?) is entered into on March 18, 2021 by and between ARYA Sciences Holdings V, a Cayman Islands |
|
| June 24, 2021 |
PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT EX-10.3 9 nt10022624x2ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT THIS PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), dated as of [●], 2021, is entered into by and between ARYA Sciences Acquisition Corp V, a Cayman Islands exempted company (the “Company”), and |
|
| June 24, 2021 |
S-1 1 nt10022624x2s1.htm S-1 TABLE OF CONTENTS As filed with the United States Securities and Exchange Commission on June 23, 2021 under the Securities Act of 1933, as amended. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ARYA Sciences Acquisition Corp V (Exact name of registran |
|
| June 24, 2021 |
Exhibit 3.2 Companies Act (Revised) Company Limited by Shares AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF ARYA SCIENCES ACQUISITION CORP V Adopted by special resolution on [ ] 2021 Companies Act (Revised) Company Limited by Shares Amended and Restated Memorandum of Association of ARYA Sciences Acquisition Corp V Adopted by special resolution on [ ] 2021 1 The name of the Company is ARYA Scie |
|
| June 24, 2021 |
ARYA SCIENCES ACQUISITION CORP V 51 Astor Place, 10th Floor New York, New York 10003 [●], 2021 Exhibit 10.5 ARYA SCIENCES ACQUISITION CORP V 51 Astor Place, 10th Floor New York, New York 10003 [?], 2021 ARYA Sciences Holdings V c/o Perceptive Advisors 51 Astor Place, 10th Floor New York, New York 10003 Ladies and Gentlemen: This letter will confirm our agreement that, commencing on the effective date (the ?Effective Date?) of the registration statement (the ?Registration Statement?) for the |
|
| June 24, 2021 |
EX-99.2 17 nt10022624x2ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 CONSENT OF JAKE BAUER ARYA Sciences Acquisition Corp V intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the unders |
|
| June 24, 2021 |
Specimen Ordinary Share Certificate.(2) Exhibit 4.1 SPECIMEN CLASS A ORDINARY SHARE CERTIFICATE NUMBER SHARES ARYA SCIENCES ACQUISITION CORP V INCORPORATED UNDER THE LAWS OF THE CAYMAN ISLANDS CLASS A ORDINARY SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP [●] This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE CLASS A ORDINARY SHARES OF THE PAR VALUE OF US $0.0001 EACH OF ARYA SCIENCES ACQUISITION CORP V (THE “COMPANY”) |
|
| June 24, 2021 |
REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT Exhibit 10.2 REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT THIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (this ?Agreement?), dated as of [?], 2021, is made and entered into by and among ARYA Sciences Acquisition Corp V, a Cayman Islands exempted company (the ?Company?), ARYA Sciences Holdings V, a Cayman Island exempted limited company (the ?Sponsor?), and the undersigned parties listed under |
|
| June 24, 2021 |
INVESTMENT MANAGEMENT TRUST AGREEMENT EX-10.1 7 nt10022624x2ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of [●], 2021 by and between ARYA Sciences Acquisition Corp V, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Compan |
|
| June 24, 2021 |
13,000,000 Class A Ordinary Shares ARYA Sciences Acquisition Corp V UNDERWRITING AGREEMENT EX-1.1 2 nt10022624x2ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 13,000,000 Class A Ordinary Shares ARYA Sciences Acquisition Corp V UNDERWRITING AGREEMENT [●], 2021 JEFFERIES LLC GOLDMAN SACHS & CO. LLC As Representatives of the several Underwriters c/o JEFFERIES LLC 520 Madison Avenue New York, New York 10022 c/o GOLDMAN SACHS & CO. LLC 200 West Street New York, New York 10282 Ladies and Gentlemen: Introd |
|
| June 24, 2021 |
Exhibit 10.6 THIS PROMISSORY NOTE (?NOTE?) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| June 24, 2021 |
EX-99.1 16 nt10022624x2ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 CONSENT OF TODD WIDER ARYA Sciences Acquisition Corp V intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the unders |
|
| June 24, 2021 |
Exhibit 10.8 [?], 2021 ARYA Sciences Acquisition Corp V 51 Astor Place, 10th Floor New York, New York 10003 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into by and among ARYA Sciences Acquisition Corp V, a Cayman Islands exempted company (the ?C |
|
| March 31, 2021 |
DRS 1 filename1.htm As submitted confidentially with the U.S. Securities and Exchange Commission on March 31, 2021. This draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confidential. No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UN |
